Be part of the knowledge.™

Ophthalmology

45

LikeLikedUnlike

1-15 of 63

MinuteCE®
Lighting the Way: Exploring the Potential of Photobiomodulation for Dry AMD Treatment
- Janis T. Eells, Ph.D.
  Peer
- David Boyer, MD
  Peer
- Diana V. Do, MD
  Peer
- Marion Munk, MD, Ph.D
  Peer
1.00 credits 8 episodes
Photobiomodulation: A Non-Invasive Treatment for Ocular Disease and Trauma
MinuteCE®
Photobiomodulation: A Non-Invasive Treatment for Ocular Disease and Trauma
- Janis T. Eells, Ph.D.
  Peer
1.00 program credits
Clinical and Safety Outcomes from the LIGHTSITE III Trial
MinuteCE®
Clinical and Safety Outcomes from the LIGHTSITE III Trial
- David Boyer, MD
  Peer
- Diana V. Do, MD
  Peer
1.00 program credits
Anatomical Outcomes from the LIGHTSITE III Trial
MinuteCE®
Anatomical Outcomes from the LIGHTSITE III Trial
- Diana V. Do, MD
  Peer
- David Boyer, MD
  Peer
1.00 program credits
Sustaining Visual Benefits of Photobiomodulation in Dry Age-Related Macular Degeneration
MinuteCE®
Sustaining Visual Benefits of Photobiomodulation in Dry Age-Related Macular Degeneration
- Marion Munk, MD, Ph.D
  Peer
- David Boyer, MD
  Peer
1.00 program credits
Best Practices for Optimized Photobiomodulation Treatment Effect: Candidate Selection
MinuteCE®
Best Practices for Optimized Photobiomodulation Treatment Effect: Candidate Selection
- Marion Munk, MD, Ph.D
  Peer
- Diana V. Do, MD
  Peer
1.00 program credits
advertisement
Patient-Centered Care and Integration of Photobiomodulation Therapy into Clinical Practice
MinuteCE®
Patient-Centered Care and Integration of Photobiomodulation Therapy into Clinical Practice
- Diana V. Do, MD
  Peer
- Marion Munk, MD, Ph.D
  Peer
1.00 program credits
Integration of Photobiomodulation Therapy into the Age-Related Macular Degeneration Treatment Landscape
MinuteCE®
Integration of Photobiomodulation Therapy into the Age-Related Macular Degeneration Treatment Landscape
- David Boyer, MD
  Peer
- Marion Munk, MD, Ph.D
  Peer
1.00 program credits
Real-World Evidence of Photobiomodulation Efficacy in Ocular Indications
MinuteCE®
Real-World Evidence of Photobiomodulation Efficacy in Ocular Indications
- Marion Munk, MD, Ph.D
  Peer
- David Boyer, MD
  Peer
1.00 program credits
Sustaining Vision: Empowering Optometry for Tomorrow’s Retinal Care
COPE ACCREDITED CE OFFERED
Sustaining Vision: Empowering Optometry for Tomorrow’s Retinal Care
- Arshad M. Khanani MD, MA, FASRS
  Peer
- Veeral Sheth, MD, MBA, FASRS, FACS
  Peer
- Lejla Vajzovic, MD, FASRS
  Peer
1.00 credits
The Role of Presbyopia-Correcting Drops
CME/CE
The Role of Presbyopia-Correcting Drops
- Mark T. Dunbar, OD, FAAO
  Peer
- David Eichenbaum, MD
  Peer
0.25 credits
Presbyopia-Correcting Drops: The Importance of Patient Selection
CME/CE
Presbyopia-Correcting Drops: The Importance of Patient Selection
- Christina Y. Weng, MD, MBA, FASRS
  Peer
- Mohammad R. Rafieetary, OD, FAAO, FORS, ABO
  Peer
0.25 credits
advertisement
MinuteCE®
Biomarking the Difference: How Second-Generation Therapies are Changing the Game
- Justis P. Ehlers, MD, FASRS
  Peer
- Roger A. Goldberg, MD, MBA
  Peer
- Jennifer, I. Lim, MD, FASRS, FARVO
  Peer
- Ehsan Rahimy, MD
  Peer
1.00 credits 10 episodes
Second-Generation Biomarkers for Treatment Outcomes
MinuteCE®
Second-Generation Biomarkers for Treatment Outcomes
- Justis P. Ehlers, MD, FASRS
  Peer
- Jennifer, I. Lim, MD, FASRS, FARVO
  Peer
1.00 program credits
Beyond Durability - What Biomarkers Reveal About Disease Control
MinuteCE®
Beyond Durability - What Biomarkers Reveal About Disease Control
- Justis P. Ehlers, MD, FASRS
  Peer
- Jennifer, I. Lim, MD, FASRS, FARVO
  Peer
1.00 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended